Rocket Lab (RKLB) just locked in its largest commercial Electron contract yet, a multiyear deal with Japan based Synspective for 20 launches that pushed the company’s backlog above 100 missions.
Rocket Lab’s share price has been choppy this year, with a 15.03% 1 month share price return sitting against a 20.59% decline over the past 3 months. However, the 1 year total shareholder return of 31.62% and very large 3 year total shareholder return signal that long term momentum has been strong as contract wins, fresh launches and capital raising for the Iridium acquisition reshape how investors price both growth potential and execution risk.
Scan how Rocket Lab’s latest backlog win compares with other contractors by reviewing the hand picked 40 power grid technology and infrastructure stocks.Rocket Lab’s latest contract pushed the backlog above 100 missions and lit a fire under the share price. Are you looking at a business inflection or a sentiment swing, and what does that imply for valuation?
Most Popular Narrative: 13% Undervalued
At a last close of $73.92 versus a narrative fair value of $85.04, Rocket Lab screens as undervalued on the most followed thesis, with that gap heavily tied to how investors view future execution rather than the latest contract headline.
Rocket Lab is mid transformation from a small launch specialist into a vertically integrated space and defense prime, with Space Systems now approximately 67% of revenue and growing fastest. A $1.85B backlog (up 73% year over year) anchored by the $816M SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of approximately 72x does not yet fully reflect.
See why 104 investors see Rocket Lab as 13% undervalued.
Result: Fair Value of $85.04 (UNDERVALUED)
Still, the whole Rocket Lab setup leans on Neutron flying cleanly and SDA contracts converting as planned, so any launch setback or defense delay could quickly flip this story.
Find out about the key risks to this Rocket Lab narrative.
Next Steps
Sentiment on Rocket Lab is split, with clear upside hopes sitting beside pointed concerns about execution risk. Move quickly, review both sides of the data, and ground your own call in the 2 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Rocket Lab?
Round out your watchlist by scanning other opportunities that match your style, so Rocket Lab sits in context rather than in isolation.
- Hunt for quality at a discount by checking the 31 high quality undervalued stocks tailored to financially stronger opportunities.
- Build staying power into your portfolio by reviewing the list of solid balance sheet and fundamentals (25 results) that highlights sturdier balance sheets.
- Spot potential early movers by scanning the 19 high quality undiscovered gems before wider attention catches up.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com